Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC
Patent protects ready to use liquid formulation of GerlinC which improves efficiency and focus for surgeons, resulting in a 10-minute procedure Robust IP portfolio includes 35 issued patents to date worldwide GerlinC is in a pivotal FDA trial, has received regulatory approval in the EU, and is the world’s first off-the-shelf regenerative treatment for knee […]